Rapid deployment of COVID-19 vaccines saved the US $438B, study says

The country’s COVID-19 vaccine rollout saved the U.S. an estimated $438 billion in terms of 2021 real gross domestic product, according to a report released Dec. 20 by think tank Heartland Forward.

Advertisement

The report said the savings brought about by the rapid deployment of COVID-10 vaccines represents 2.3 percent of real gross domestic product in 2021.

“While there is much uncertainty surrounding omicron and future variants, with the proper tools and facilitation of this vaccine, we will continue to experience economic benefits,” ​​Anusuya Chatterjee, PhD, Heartland Forward’s director of health research, said in a statement. “The U.S. should take lessons from the incredible public-private partnerships and deploy these strategies to address future crises.”

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.